July 24, 2017
Endologix Inc. urged a California federal judge Friday to sanction a shareholder whose amended complaint allegedly hinges on false statements made by a single witness in a proposed class action claiming the medical device maker misrepresented the likelihood that a product would be approved by the U.S. Food and Drug Administration, causing its stock to plunge.